JP2025142197A5 - - Google Patents
Info
- Publication number
- JP2025142197A5 JP2025142197A5 JP2025078577A JP2025078577A JP2025142197A5 JP 2025142197 A5 JP2025142197 A5 JP 2025142197A5 JP 2025078577 A JP2025078577 A JP 2025078577A JP 2025078577 A JP2025078577 A JP 2025078577A JP 2025142197 A5 JP2025142197 A5 JP 2025142197A5
- Authority
- JP
- Japan
- Prior art keywords
- following structure
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980143P | 2020-02-21 | 2020-02-21 | |
| US62/980,143 | 2020-02-21 | ||
| PCT/US2021/019113 WO2021168446A1 (en) | 2020-02-21 | 2021-02-22 | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
| JP2022550119A JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550119A Division JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025142197A JP2025142197A (ja) | 2025-09-30 |
| JP2025142197A5 true JP2025142197A5 (enExample) | 2025-10-07 |
Family
ID=77391353
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550119A Withdrawn JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
| JP2025078577A Pending JP2025142197A (ja) | 2020-02-21 | 2025-05-09 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550119A Withdrawn JP2023515101A (ja) | 2020-02-21 | 2021-02-22 | 神経変性疾患及びミトコンドリア病の治療用の組成物ならびにその使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20240018146A1 (enExample) |
| EP (1) | EP4106874A4 (enExample) |
| JP (2) | JP2023515101A (enExample) |
| KR (1) | KR20220158290A (enExample) |
| CN (1) | CN115515682B (enExample) |
| AU (1) | AU2021222053A1 (enExample) |
| BR (1) | BR112022016614A2 (enExample) |
| CA (1) | CA3168531A1 (enExample) |
| CO (1) | CO2022013603A2 (enExample) |
| CR (1) | CR20220476A (enExample) |
| EC (1) | ECSP22074210A (enExample) |
| IL (1) | IL295681A (enExample) |
| MX (1) | MX2022010309A (enExample) |
| PH (1) | PH12022552518A1 (enExample) |
| WO (1) | WO2021168446A1 (enExample) |
| ZA (1) | ZA202210409B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020253561A1 (en) * | 2019-04-03 | 2021-12-02 | Mitokinin, Inc. | Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease |
| CN119752781B (zh) * | 2025-03-04 | 2025-07-01 | 中国农业大学 | 缓解成熟卵子老化的组合物、培养液、产品及方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9604361D0 (en) * | 1996-02-29 | 1996-05-01 | Pharmacia Spa | 4-Substituted pyrrolopyrimidine compounds as tyrosine kinase inhibitors |
| TW200508224A (en) * | 2003-02-12 | 2005-03-01 | Bristol Myers Squibb Co | Cyclic derivatives as modulators of chemokine receptor activity |
| JP5231251B2 (ja) * | 2006-02-02 | 2013-07-10 | ミレニアム ファーマシューティカルズ， インコーポレイテッド | Ｅ１活性化酵素の阻害剤 |
| WO2008033747A2 (en) * | 2006-09-11 | 2008-03-20 | Curis, Inc. | Multi-functional small molecules as anti-proliferative agents |
| EP2342178B1 (en) * | 2008-09-02 | 2016-09-28 | Sanofi | Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| NZ710444A (en) * | 2013-02-11 | 2020-08-28 | Univ California | Compositions and methods for treating neurodegenerative diseases and cardiomyopathy |
| CA3067695A1 (en) * | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
-
2021
- 2021-02-22 BR BR112022016614A patent/BR112022016614A2/pt unknown
- 2021-02-22 CR CR20220476A patent/CR20220476A/es unknown
- 2021-02-22 CN CN202180025593.5A patent/CN115515682B/zh active Active
- 2021-02-22 AU AU2021222053A patent/AU2021222053A1/en active Pending
- 2021-02-22 CA CA3168531A patent/CA3168531A1/en active Pending
- 2021-02-22 PH PH1/2022/552518A patent/PH12022552518A1/en unknown
- 2021-02-22 WO PCT/US2021/019113 patent/WO2021168446A1/en not_active Ceased
- 2021-02-22 KR KR1020227032526A patent/KR20220158290A/ko active Pending
- 2021-02-22 US US17/801,450 patent/US20240018146A1/en active Pending
- 2021-02-22 IL IL295681A patent/IL295681A/en unknown
- 2021-02-22 JP JP2022550119A patent/JP2023515101A/ja not_active Withdrawn
- 2021-02-22 EP EP21757063.9A patent/EP4106874A4/en active Pending
- 2021-02-22 MX MX2022010309A patent/MX2022010309A/es unknown
-
2022
- 2022-09-20 ZA ZA2022/10409A patent/ZA202210409B/en unknown
- 2022-09-21 CO CONC2022/0013603A patent/CO2022013603A2/es unknown
- 2022-09-21 EC ECSENADI202274210A patent/ECSP22074210A/es unknown
-
2025
- 2025-05-09 JP JP2025078577A patent/JP2025142197A/ja active Pending